2026-02-09 21:32:10

I’ve been told that $HIMS is fighting Big Pharma

If that were the case, why would they pull oral GLP-1?
If they were in the right, why not keep it?
The answer is simple. If things went wrong, it could not only hit the company, it could hit management personally
Once a consumer uses a pill that is later proven to be ineffective, management can be sued for consumer fraud
Anyone involved in deceptive marketing is potentially liable under FTC law
The FTC has taken action not only against product marketers, but also, in certain cases, against individual owners and corporate officers
That means fines and penalties for individuals, not just the entity
In other words, risking investors’ money was acceptable. The line was drawn where management itself could face personal prosecution

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.